• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases

tetano

Editor, Senior Moderator
Cureus


. 2021 Nov 5;13(11):e19291.
doi: 10.7759/cureus.19291. eCollection 2021 Nov.
Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases


Aditya Patel[SUP] 1 [/SUP], Folasade Ajayi[SUP] 1 [/SUP], Ruhma Ali[SUP] 1 [/SUP], Kok Hoe Chan[SUP] 2 [/SUP], Jihad Slim[SUP] 3 [/SUP]



Affiliations

Abstract

Severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection can be a life-threatening disease, which has emerged as a public health hazard. Thrombotic events have been reported in hospitalized patients with severe disease however scarce data is available regarding the screening of thromboembolic disease and pulmonary embolism in those with mild or asymptomatic infection. Herein, we describe the development of pulmonary embolism in two asymptomatic patients with COVID-19 and suggest the need for close monitoring and anticoagulation to prevent this life-threatening complication.

Keywords: covid-19; deep vein thrombosis (dvt); pulmonary embolism (pe); sars-cov-2 (severe acute respiratory syndrome coronavirus -2); therapeutic anticoagulation.
 
Back
Top Bottom